| Escitalopram |
20090436 |
Elicea, Film coated tablet, 20, mg, Pack: 28 |
KRKA, d.d., Словения |
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Словения |
13.1 |
2.62 |
15.72 |
6% |
0.79 |
13.89 |
2.78 |
16.67 |
18% |
2.36 |
16.25 |
3.25 |
19.5 |
|
НСР-6688/09.07.2015 |
25.07.2015 |
25.07.2015 |
Неактивен |
4032 |
| Venlafaxine |
20080092 |
Elify XR, prolonged‐release capsule, hard, 150, mg, Pack: 30 |
Medochemie Ltd., Кипър |
Medochemie Ltd., Cyprus |
12.58 |
2.52 |
15.1 |
6% |
0.75 |
13.33 |
2.67 |
16 |
18% |
2.26 |
15.59 |
3.12 |
18.71 |
Цената се заличава с решение НСР-3149/26.03.2014 |
HCР-521/11.07.2013. |
29.07.2013 |
29.07.2013 |
Заличен |
1972 |
| Venlafaxine |
II-2248/ 11.06.2008 |
Elify XR, prolonged‐release capsule, hard, 150, mg, Pack: 30 |
Medochemie Ltd., Кипър |
Medochemie Ltd, Cyprus |
31.8 |
6.36 |
38.16 |
4% |
1.27 |
33.07 |
6.61 |
39.68 |
16% |
5.09 |
38.16 |
7.63 |
45.79 |
|
КЦРР-210/27.02.2012 |
20.03.2012 |
20.03.2012 |
Неактивен |
1972 |
| Venlafaxine |
II-2248/11.06.2008 |
Elify XR, prolonged‐release capsule, hard, 150, mg, Pack: 30 |
Medochemie Ltd., Кипър |
Medochemie Ltd, Cyprus |
42.25 |
8.45 |
50.7 |
6% |
2.54 |
44.79 |
8.96 |
53.75 |
18% |
7.61 |
52.4 |
10.48 |
62.88 |
|
КЦ-494/04.02.2009 |
24.02.2009 |
24.02.2009 |
Неактивен |
1972 |
| Venlafaxine |
20080091 |
ELIFY XR, Prolonged release capsule, hard, 75, mg, Pack: 30 |
Medochemie Ltd., Кипър |
Medochemie Ltd., Cyprus |
5.32 |
1.06 |
6.38 |
7% |
0.37 |
5.69 |
1.14 |
6.83 |
20% |
1.06 |
6.75 |
1.35 |
8.1 |
Корекционно решение НСР-18621/25.04.2019 |
HCР-7710/17.12.2015; НСР-18287/28.03.2019 |
12.04.2019 |
02.06.2019 |
Активен |
1971 |
| Venlafaxine |
20080091 |
ELIFY XR, Prolonged release capsule, hard, 75, mg, Pack: 30 |
Medochemie Ltd., Кипър |
Medochemie Ltd., Cyprus |
5.32 |
1.06 |
6.38 |
7% |
0.37 |
5.69 |
1.14 |
6.83 |
20% |
1.06 |
6.75 |
1.35 |
8.1 |
|
HCР-7710/17.12.2015; НСР-18287/28.03.2019 |
12.04.2019 |
02.05.2019 |
Неактивен |
1971 |
| Venlafaxine |
20080091 |
ELIFY XR, Prolonged release capsule, hard, 75, mg, Pack: 30 |
Medochemie Ltd., Кипър |
Medochemie Ltd., Cyprus |
6.45 |
1.29 |
7.74 |
7% |
0.45 |
6.9 |
1.38 |
8.28 |
20% |
1.29 |
8.19 |
1.64 |
9.83 |
|
HCР-7710/17.12.2015 |
02.01.2016 |
02.01.2016 |
Неактивен |
1971 |
| Venlafaxine |
20080091 |
ELIFY XR, Prolonged release capsule, hard, 75, mg, Pack: 30 |
Medochemie Ltd., Кипър |
Medochemie Ltd., Cyprus |
7.63 |
1.53 |
9.16 |
7% |
0.53 |
8.16 |
1.63 |
9.79 |
20% |
1.53 |
9.69 |
1.94 |
11.63 |
|
HCР-522/11.07.2013. |
29.07.2013 |
29.07.2013 |
Неактивен |
1971 |
| Venlafaxine |
II-2247/ 11.06.2008 |
ELIFY XR, Prolonged release capsule, hard, 75, mg, Pack: 30 |
Medochemie Ltd., Кипър |
Medochemie Ltd, Cyprus |
15.69 |
3.14 |
18.83 |
6% |
0.94 |
16.63 |
3.33 |
19.96 |
18% |
2.82 |
19.45 |
3.89 |
23.34 |
|
КЦРР-210/27.02.2012 |
20.03.2012 |
20.03.2012 |
Неактивен |
1971 |
| Venlafaxine |
II-2247/11.06.2008 |
ELIFY XR, Prolonged release capsule, hard, 75, mg, Pack: 30 |
Medochemie Ltd., Кипър |
Medochemie Ltd, Cyprus |
21.32 |
4.26 |
25.58 |
8% |
1.71 |
23.03 |
4.61 |
27.64 |
20% |
4.26 |
27.29 |
5.46 |
32.75 |
|
КЦ-494/04.02.2009 |
24.02.2009 |
24.02.2009 |
Неактивен |
1971 |
| Leuprorelin |
20070097 |
ELIGARD, Powder and solvent for solution for injection, 45, mg, Pack: 1 |
Astellas Pharma d.o.o, Словения |
Astellas Pharma Europe B.V., The Netherlands |
538.19 |
107.64 |
645.83 |
4% |
10 |
548.19 |
109.64 |
657.83 |
16% |
25 |
573.19 |
114.64 |
687.83 |
Корекционно решение НСР-16848/20.09.2018 |
НСР-6144/29.04.2015.; НСР-9624/23.06.2016г.; НСР-12144/27.03.2017 г.; НСР-14905/25.01.2018; НСР-17239/12.11.2018 предварително изпълнение; НСР-19369/26.07.2019 предварително изпълнение |
26.07.2019 |
02.09.2019 |
Активен |
3859 |
| Leuprorelin |
20070097 |
ELIGARD, Powder and solvent for solution for injection, 45, mg, Pack: 1 |
Astellas Pharma d.o.o, Словения |
Astellas Pharma Europe B.V., The Netherlands |
538.19 |
107.64 |
645.83 |
4% |
10 |
548.19 |
109.64 |
657.83 |
16% |
25 |
573.19 |
114.64 |
687.83 |
Корекционно решение НСР-16848/20.09.2018 |
НСР-6144/29.04.2015.; НСР-9624/23.06.2016г.; НСР-12144/27.03.2017 г.; НСР-14905/25.01.2018; НСР-17239/12.11.2018 предварително изпълнение; НСР-19369/26.07.2019 предварително изпълнение |
26.07.2019 |
02.09.2019 |
Неактивен |
3859 |
| Leuprorelin |
20070097 |
ELIGARD, Powder and solvent for solution for injection, 45, mg, Pack: 1 |
Astellas Pharma d.o.o, Словения |
Astellas Pharma Europe B.V., The Netherlands |
538.19 |
107.64 |
645.83 |
4% |
10 |
548.19 |
109.64 |
657.83 |
16% |
25 |
573.19 |
114.64 |
687.83 |
Корекционно решение НСР-16848/20.09.2018 |
НСР-6144/29.04.2015.; НСР-9624/23.06.2016г.; НСР-12144/27.03.2017 г.; НСР-14905/25.01.2018; НСР-17239/12.11.2018 предварително изпълнение; НСР-19369/26.07.2019 предварително изпълнение* |
26.07.2019 |
02.08.2019 |
Неактивен |
3859 |
| Leuprorelin |
20070097 |
ELIGARD, Powder and solvent for solution for injection, 45, mg, Pack: 1 |
Astellas Pharma d.o.o, Словения |
Astellas Pharma Europe B.V., The Netherlands |
553.79 |
110.76 |
664.55 |
4% |
10 |
563.79 |
112.76 |
676.55 |
16% |
25 |
588.79 |
117.76 |
706.55 |
Корекционно решение НСР-16848/20.09.2018 |
НСР-6144/29.04.2015.; НСР-9624/23.06.2016г.; НСР-12144/27.03.2017 г.; НСР-14905/25.01.2018; НСР-17239/12.11.2018 предварително изпълнение |
12.11.2018 |
02.12.2018 |
Неактивен |
3859 |
| Leuprorelin |
20070097 |
ELIGARD, Powder and solvent for solution for injection, 45, mg, Pack: 1 |
Astellas Pharma d.o.o, Словения |
Astellas Pharma Europe B.V., The Netherlands |
598.7 |
119.74 |
718.44 |
4% |
10 |
608.7 |
121.74 |
730.44 |
16% |
25 |
633.7 |
126.74 |
760.44 |
Корекционно решение НСР-16848/20.09.2018 |
НСР-6144/29.04.2015.; НСР-9624/23.06.2016г.; НСР-12144/27.03.2017 г.; НСР-14905/25.01.2018 |
09.02.2018 |
02.03.2018 |
Неактивен |
3859 |
| Leuprorelin |
20070097 |
ELIGARD, Powder and solvent for solution for injection, 45, mg, Pack: 1 |
Astellas Pharma d.o.o, Словения |
Astellas Pharma Europe B.V., The Netherlands |
598.7 |
119.74 |
718.44 |
4% |
10 |
608.7 |
121.74 |
730.44 |
16% |
25 |
633.7 |
126.74 |
760.44 |
|
НСР-6144/29.04.2015.; НСР-9624/23.06.2016г.; НСР-12144/27.03.2017 г.; НСР-14905/25.01.2018 |
09.02.2018 |
02.03.2018 |
Неактивен |
3859 |
| Leuprorelin |
20070097 |
ELIGARD, Powder and solvent for solution for injection, 45, mg, Pack: 1 |
Astellas Pharma d.o.o, Словения |
Astellas Pharma Europe B.V., The Netherlands |
611.55 |
122.31 |
733.86 |
4% |
10 |
621.55 |
124.31 |
745.86 |
16% |
25 |
646.55 |
129.31 |
775.86 |
|
НСР-6144/29.04.2015.; НСР-9624/23.06.2016г.; НСР-12144/27.03.2017 г. |
11.04.2017 |
02.05.2017 |
Неактивен |
3859 |
| Leuprorelin |
20070097 |
ELIGARD, Powder and solvent for solution for injection, 45, mg, Pack: 1 |
Astellas Pharma d.o.o, Словения |
Astellas Pharma Europe B.V., The Netherlands |
689.29 |
137.86 |
827.15 |
4% |
10 |
699.29 |
139.86 |
839.15 |
16% |
25 |
724.29 |
144.86 |
869.15 |
|
НСР-6144/29.04.2015.; НСР-9624/23.06.2016г. |
02.08.2016 |
02.08.2016 |
Неактивен |
3859 |
| Leuprorelin |
20070097 |
ELIGARD, Powder and solvent for solution for injection, 45, mg, Pack: 1 |
Astellas Pharma d.o.o, Словения |
Astellas Pharma Europe B.V., The Netherlands |
690.98 |
138.2 |
829.18 |
4% |
10 |
700.98 |
140.2 |
841.18 |
16% |
25 |
725.98 |
145.2 |
871.18 |
|
НСР-6144/29.04.2015. |
14.05.2015 |
14.05.2015 |
Неактивен |
3859 |
| Leuprorelin |
20060216 |
ELIGARD, Solution for injection, 7.5, mg, Pack: 1 |
Astellas Pharma d.o.o, Словения |
Astellas Pharma Europe B.V., The Netherlands |
107.61 |
21.52 |
129.13 |
4% |
4.3 |
111.91 |
22.38 |
134.29 |
16% |
17.22 |
129.13 |
25.83 |
154.96 |
цената е заличена с решение НСР-6528/24.06.2015 (в сила от 16.07.2015 ) |
НСР-6226/21.05.2015 |
04.06.2015 |
04.06.2015 |
Заличен |
3201 |
| Leuprorelin |
20070097 |
ELIGARD, Solution for injection, 22.5, mg, Pack: 1 |
Astellas Pharma d.o.o, Словения |
Astellas Pharma Europe B.V., The Netherlands |
324.22 |
64.84 |
389.06 |
4% |
10 |
334.22 |
66.84 |
401.06 |
16% |
25 |
359.22 |
71.84 |
431.06 |
цената е заличена с решение НСР-6529/24.06.2015 (в сила от 16.07.2015 ) |
НСР-6227/21.05.2015 |
04.06.2015 |
04.06.2015 |
Заличен |
3200 |
| Leuprorelin |
20060216 |
ELIGARD, Solution for injection, 7.5, mg, Pack: 1 |
Astellas Pharma d.o.o, Словения |
Astellas Pharma Europe B.V., The Netherlands |
137.65 |
27.53 |
165.18 |
4% |
5.51 |
143.16 |
28.63 |
171.79 |
16% |
22.02 |
165.18 |
33.04 |
198.22 |
|
НСР-4652/25.09.2014 |
09.10.2014 |
09.10.2014 |
Неактивен |
3201 |
| Leuprorelin |
20070097 |
ELIGARD, Solution for injection, 22.5, mg, Pack: 1 |
Astellas Pharma d.o.o, Словения |
Astellas Pharma Europe B.V., The Netherlands |
354.46 |
70.89 |
425.35 |
4% |
10 |
364.46 |
72.89 |
437.35 |
16% |
25 |
389.46 |
77.89 |
467.35 |
|
НСР-4653/25.09.2014 |
09.10.2014 |
09.10.2014 |
Неактивен |
3200 |
| Leuprorelin |
20070097 |
ELIGARD, Powder and solvent for solution for injection, 45, mg, Pack: 1 |
Astellas Pharma d.o.o, Словения |
Astellas Pharma Europe B.V., The Netherlands |
708.75 |
141.75 |
850.5 |
4% |
10 |
718.75 |
143.75 |
862.5 |
16% |
25 |
743.75 |
148.75 |
892.5 |
корекц решение НСР-3225/14.04.2014 |
НСР-2509/24.01.2014 |
21.03.2014 |
21.03.2014 |
Неактивен |
3859 |
| Leuprorelin |
20070097 |
ELIGARD, Solution for injection, 22.5, mg, Pack: 1 |
Astellas Pharma d.o.o, Словения |
Astellas Pharma Europe B.V., The Netherlands |
371.43 |
74.29 |
445.72 |
4% |
10 |
381.43 |
76.29 |
457.72 |
16% |
25 |
406.43 |
81.29 |
487.72 |
промяна на обстоятелства НСР-934/12.08.2013 |
НСР-447/09.07.2013 |
30.07.2013 |
30.07.2013 |
Неактивен |
3200 |